COFCO Biotechnology Co., Ltd. (SHE:000930)
China
· Delayed Price · Currency is CNY 7.21
-0.33 (-4.38%)
Mar 10, 2026, 2:15 PM CST
COFCO Biotechnology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 13,998 | 10,321 | 12,382 | 15,594 | 20,280 | 15,710 | Upgrade
|
| Market Cap Growth | 38.61% | -16.64% | -20.60% | -23.11% | 29.09% | 28.83% | Upgrade
|
| Enterprise Value | 16,032 | 13,093 | 15,361 | 17,467 | 22,540 | 19,444 | Upgrade
|
| Last Close Price | 7.54 | 5.55 | 6.64 | 7.77 | 9.84 | 7.57 | Upgrade
|
| PE Ratio | 148.63 | 410.73 | - | 14.73 | 17.95 | 26.49 | Upgrade
|
| Forward PE | - | 17.58 | 17.58 | 17.58 | 17.58 | 17.58 | Upgrade
|
| PS Ratio | 0.77 | 0.52 | 0.61 | 0.78 | 0.86 | 0.79 | Upgrade
|
| PB Ratio | 1.26 | 0.95 | 1.14 | 1.25 | 1.73 | 1.45 | Upgrade
|
| P/TBV Ratio | 1.45 | 1.08 | 1.31 | 1.40 | 1.95 | 1.71 | Upgrade
|
| P/FCF Ratio | 21.69 | - | 9.36 | 109.31 | 5.43 | - | Upgrade
|
| P/OCF Ratio | 11.03 | 66.24 | 6.32 | 22.01 | 4.19 | - | Upgrade
|
| EV/Sales Ratio | 0.88 | 0.65 | 0.75 | 0.88 | 0.96 | 0.98 | Upgrade
|
| EV/EBITDA Ratio | 26.70 | 21.68 | 326.11 | 8.88 | 10.64 | 15.74 | Upgrade
|
| EV/EBIT Ratio | 183.42 | 106.93 | - | 11.44 | 13.38 | 24.33 | Upgrade
|
| EV/FCF Ratio | 24.84 | - | 11.61 | 122.43 | 6.04 | - | Upgrade
|
| Debt / Equity Ratio | 0.38 | 0.41 | 0.34 | 0.26 | 0.29 | 0.63 | Upgrade
|
| Debt / EBITDA Ratio | 6.91 | 7.08 | 50.53 | 1.62 | 1.59 | 5.53 | Upgrade
|
| Debt / FCF Ratio | 6.43 | - | 2.75 | 22.61 | 0.91 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.15 | 0.23 | 0.20 | 0.18 | 0.19 | 0.57 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.82 | 4.16 | 45.90 | 1.12 | 1.08 | 4.99 | Upgrade
|
| Net Debt / FCF Ratio | 2.53 | -7.67 | 1.63 | 15.46 | 0.61 | -1.58 | Upgrade
|
| Asset Turnover | 1.06 | 1.18 | 1.18 | 1.10 | 1.22 | 1.06 | Upgrade
|
| Inventory Turnover | 7.90 | 7.13 | 6.29 | 4.57 | 4.67 | 4.66 | Upgrade
|
| Quick Ratio | 1.00 | 0.57 | 0.55 | 0.50 | 0.47 | 0.22 | Upgrade
|
| Current Ratio | 1.71 | 1.17 | 1.17 | 1.49 | 1.37 | 1.06 | Upgrade
|
| Return on Equity (ROE) | 0.97% | 0.42% | -5.28% | 8.74% | 10.02% | 5.98% | Upgrade
|
| Return on Assets (ROA) | 0.32% | 0.45% | -1.51% | 5.28% | 5.46% | 2.65% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.48% | 0.33% | -3.03% | 8.29% | 8.91% | 4.25% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.70% | 1.10% | -3.70% | 11.80% | 13.50% | 7.20% | Upgrade
|
| Earnings Yield | 0.68% | 0.24% | -4.86% | 6.79% | 5.57% | 3.77% | Upgrade
|
| FCF Yield | 4.61% | -3.17% | 10.69% | 0.92% | 18.40% | -24.82% | Upgrade
|
| Dividend Yield | - | - | - | 7.33% | 2.49% | 0.86% | Upgrade
|
| Payout Ratio | 94.85% | 371.98% | - | 52.41% | 24.55% | 27.71% | Upgrade
|
| Buyback Yield / Dilution | -0.72% | -1.08% | 0.85% | -0.45% | 0.18% | -0.27% | Upgrade
|
| Total Shareholder Return | -0.72% | -1.08% | 0.85% | 6.88% | 2.67% | 0.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.